References
- Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008;371:1030–1043.
- Bleyer W. Methotrexate: clinical pharmacology, current status and therapeutic guidelines. Cancer Treat Rev 1977;4:87–101.
- Scientific leaflet methotrexate [in Flemish]. Available from: http://www.bcfi.be/
- Clinical pharmacology [online database]. Tampa, FL: Gold Standard, Inc.; 2012. Available from: http://www.clinicalpharmacology.com
- Evans WE, Relling MV, Rodman JH, . Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. N Engl J Med 1998;338:499–505.
- De Vries EG, Meyer C, Strubbe M, . Influence of various beverages on urine acid output. Cancer Res 1986;46:430–432.
- Santucci R, Levêque D, Herbrecht R. Cola beverage and delayed elimination of methotrexate. Br J Clin Pharmacol 2010;70:762–764.
- De Moerloose B, Suciu S, Bertrand Y, . Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951. Blood. 2010; 116:36–44.
- Levêque D, Santucci R, Gourieux B, . Pharmacokinetic drug-drug interactions with methotrexate in oncology. Expert Rev Clin Pharmacol 2011;4:743–750.
- Bezabeh S, Mackey AC, Kluetz P, . Accumulating evidence for a drug-drug interaction between methotrexate and proton pump inhibitors. Oncologist 2012;17:550–554.
- Bauters TG, Verlooy J, Robays H, . Interaction between methotrexate and omeprazole in an adolescent with leukemia: a case report. Pharm World Sci 2008;30:316–318.
- Hjorth L, Wiebe T, Karpman D. Hyperfiltration evaluated by glomerular filtration rate at diagnosis in children with cancer. Pediatr Blood Cancer 2011;56:762–766.